Home
About KRI
Mission & History
Need for Research
Support the KRI
Newsletters
Announcements
Community
Community Connection
Resources
People
Director
Investigators
Research & Administrative Staff
Patient Advisory Committee
Scientific Advisory Committee
Former Scientific Advisory Committee Members
Research
Join A Study
Active Research Studies
Completed Research Studies
Kidney Precision Medicine Project
Blossom Study
Seattle Kidney Study
Publications
Collaborating Organizations
Research Tools
Vitamin D Calculator
Urine Phosphate Calculator
Contact Us
General Inquiries & Location
Employment
News Media
SIGN UP FOR OUR NEWSLETTER
Home
About KRI
Mission & History
Need for Research
Support the KRI
Newsletters
Announcements
Community
Community Connection
Resources
People
Director
Investigators
Research & Administrative Staff
Patient Advisory Committee
Scientific Advisory Committee
Former Scientific Advisory Committee Members
Research
Join A Study
Active Research Studies
Completed Research Studies
Kidney Precision Medicine Project
Blossom Study
Seattle Kidney Study
Publications
Collaborating Organizations
Research Tools
Vitamin D Calculator
Urine Phosphate Calculator
Contact Us
General Inquiries & Location
Employment
News Media
SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease.
« A turning point for chronic kidney disease in diabetes. | previous article
next article | Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. »
